These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 14726812)

  • 1. ACMG statement on direct-to-consumer genetic testing.
    American College of Medicine Genetics Board of Directors
    Genet Med; 2004; 6(1):60. PubMed ID: 14726812
    [No Abstract]   [Full Text] [Related]  

  • 2. Direct-to-consumer genetic testing: access and marketing.
    McCabe LL; McCabe ER
    Genet Med; 2004; 6(1):58-9. PubMed ID: 14726811
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetics and managed care: Policy statement of the American College of Medical Genetics.
    Williams MS
    Genet Med; 2001; 3(6):430-5. PubMed ID: 11715009
    [No Abstract]   [Full Text] [Related]  

  • 4. CCMG statement on direct-to-consumer genetic testing.
    ; Nelson TN; Armstrong L; Richer J; Evans J; Lauzon J; McGillivray B; Bruyere H; Dougan S
    Clin Genet; 2012 Jan; 81(1):1-3. PubMed ID: 21943145
    [No Abstract]   [Full Text] [Related]  

  • 5. Direct-to-consumer genetics and health policy: a worst-case scenario?
    Caulfield T
    Am J Bioeth; 2009; 9(6-7):48-50. PubMed ID: 19998115
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic testing.
    Boylan M
    Camb Q Healthc Ethics; 2002; 11(3):246-56. PubMed ID: 12082905
    [No Abstract]   [Full Text] [Related]  

  • 7. Personal genome testing: do you know what you are buying?
    Howard HC; Borry P
    Am J Bioeth; 2009; 9(6-7):11-3. PubMed ID: 19998102
    [No Abstract]   [Full Text] [Related]  

  • 8. Are guidelines for genetic testing of children necessary?
    Fenwick A
    Fam Cancer; 2010 Mar; 9(1):23-5. PubMed ID: 19685282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996.
    J Clin Oncol; 1996 May; 14(5):1730-6; discussion 1737-40. PubMed ID: 8622094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Access to reproductive options after prenatal diagnosis-patient access and physician responsibilities: an updated position statement of the American College of Medical Genetics and Genomics (ACMG).
    ACMG Board of Directors
    Genet Med; 2020 Jan; 22(1):3. PubMed ID: 31578470
    [No Abstract]   [Full Text] [Related]  

  • 12. Statement of the ESHG on direct-to-consumer genetic testing for health-related purposes.
    European Society of Human Genetics
    Eur J Hum Genet; 2010 Dec; 18(12):1271-3. PubMed ID: 20736974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. General practitioner attitudes to direct-to-consumer genetic testing in New Zealand.
    Ram S; Russell B; Gubb M; Taylor R; Butler C; Khan I; Shelling A
    N Z Med J; 2012 Oct; 125(1364):14-26. PubMed ID: 23242394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy and ambiguity in counseling patients about genetic risk.
    Lloyd FJ; Reyna VF; Whalen P
    Arch Intern Med; 2001 Nov; 161(20):2411-3. PubMed ID: 11700153
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical implications and considerations for evaluation of in silico algorithms for use with ACMG/AMP clinical variant interpretation guidelines.
    Bean LJH; Hegde MR
    Genome Med; 2017 Dec; 9(1):111. PubMed ID: 29254502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACMG/ASHG statement. Laboratory guidelines for Huntington disease genetic testing. The American College of Medical Genetics/American Society of Human Genetics Huntington Disease Genetic Testing Working Group.
    Am J Hum Genet; 1998 May; 62(5):1243-7. PubMed ID: 9545416
    [No Abstract]   [Full Text] [Related]  

  • 17. American College of Medical Genetics position statement on gene patents and accessibility of gene testing.
    Genet Med; 1999; 1(5):237. PubMed ID: 11256680
    [No Abstract]   [Full Text] [Related]  

  • 18. The use of ACMG secondary findings recommendations for general population screening: a policy statement of the American College of Medical Genetics and Genomics (ACMG).
    ACMG Board of Directors
    Genet Med; 2019 Jul; 21(7):1467-1468. PubMed ID: 31019278
    [No Abstract]   [Full Text] [Related]  

  • 19. A national dialogue on genetics and minority issues.
    Mittman IS; Secundy MG
    Community Genet; 1998; 1(3):190-200. PubMed ID: 11657309
    [No Abstract]   [Full Text] [Related]  

  • 20. Points to consider in preventing unfair discrimination based on genetic disease risk: a position statement of the American College of Medical Genetics.
    Watson MS; Greene CL
    Genet Med; 2001; 3(6):436-7. PubMed ID: 11715011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.